Fluvastatin improves insulin resistance in nondiabetic dyslipidemic patients (Q44686551)

5 December 2017

Fluvastatin improves insulin resistance in nondiabetic dyslipidemic patients (English)

1 reference

5 December 2017

1 reference

1 reference

Alper Sonmez

1

1 reference

5 December 2017

Yavuz Baykal

2

1 reference

5 December 2017

Metin Kilic

3

1 reference

5 December 2017

M Ilker Yilmaz

4

1 reference

5 December 2017

Kenan Saglam

5

1 reference

5 December 2017

Fatih Bulucu

6

1 reference

5 December 2017

I Hakki Kocar

7

1 reference

5 December 2017

1 November 2003

1 reference

5 December 2017

1 reference

5 December 2017

22

1 reference

5 December 2017

151-154

1 reference

5 December 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1385/endo:22:2:151

5 December 2017

0 references

cites work

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas

1 reference

12 December 2020

Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population.

1 reference

12 December 2020

Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.

1 reference

12 December 2020

Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).

1 reference

12 December 2020

Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes

1 reference

12 December 2020

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

1 reference

12 December 2020

A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia

1 reference

12 December 2020

Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.

1 reference

12 December 2020

Recent advances in our understanding of insulin action and insulin resistance

1 reference

12 December 2020

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.

1 reference

12 December 2020

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

12 December 2020

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study

1 reference

12 December 2020

Mechanisms of glucose intolerance during triglyceride infusion

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes

1 reference

12 December 2020

Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later.

1 reference

12 December 2020

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

12 December 2020

Identifiers

DOI

10.1385/ENDO:22:2:151

1 reference

Dimensions Publication ID

5 December 2017

0 references

1 reference